Wasatch Microfluidics

SALT LAKE CITY, UT 84103

SBIR Award Summary

Total Number of Awards 13
Total Value of Awards $5MM
First Award Date 06/15/08
Most Recent Award Date 07/01/17

Key Personnel

Last Name Name Awards Contact
Gale Bruce Gale 9
Neilsen Paul O Neilsen 1
Smith James Sherwood Smith 2
Brooks Benjamin Delbert Brooks 8
Myszka David G. Myszka 7
JANAT-AMSBURY MARGIT MARIA JANAT-AMSBURY 1
COHEN GARY H COHEN 3
EISENBERG ROSELYN J EISENBERG 3
BAILEY-KELLOGG CHRIS BAILEY-KELLOGG 1

13 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-14-088
Budget: 07/01/17 - 06/30/18

Abstract: Vaccines are fundamental in preventing debilitating illnesses and saving millions of lives each year. But despite these vaccine-oriented victories, infectious diseases are still the second leading cause of death as well as the leading cause of disability-adjusted life years worldwide. About six million deaths were attributed to AIDS, m...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-16-302
Budget: 02/01/17 - 01/31/18

Abstract. All therapeutic antibodies and most vaccines critically depend on the ability of antibodies to specifically recognize particular antigens; consequently, detailed characterization of antibody:antigen binding can provide invaluable information to understand and guide development. Unfortunately, due to the time and expense required, atomi...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-14-088
Budget: 07/01/16 - 06/30/17

Abstract: Vaccines are fundamental in preventing debilitating illnesses and saving millions of lives eachyear. But despite these vaccine-oriented victories, infectious diseases are still the second leading cause ofdeath as well as the leading cause of disability-adjusted life years worldwide. About six million deaths wereattributed to AIDS, mala...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-088
Budget: 05/01/16 - 04/30/17

DESCRIPTION (provided by applicant): Real-time label-free technologies such as surface plasmon resonance biosensors provide high-resolution information about the kinetics, affinity, stoichiometry, activity, and specificity, of two (or more) binding partners. While the application f biosensors is well established, current instrumentation has limi...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-088
Budget: 09/01/15 - 04/30/16

DESCRIPTION (provided by applicant): Real-time label-free technologies such as surface plasmon resonance biosensors provide high-resolution information about the kinetics, affinity, stoichiometry, activity, and specificity, of two (or more) binding partners. While the application f biosensors is well established, current instrumentation has limi...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-088
Budget: 07/15/14 - 06/30/15

Project Summary We propose an instrument system for automated, multiplexed cell- and tissue-based experiments (i.e. tissue microarrays) called the Microfluidic Flow Cell Array (MFCA). The MFCA consists of a microfluidic flow cell array integrated with an inverted fluorescent microscope, allowing the observation of 48 flow chambers simultaneously...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-088
Budget: 05/01/14 - 04/30/15

Abstract Real-time label-free technologies such as surface plasmon resonance biosensors provide high-resolution information about the kinetics, affinity, stoichiometry, activity, and specificity, of two (or more) binding partners. While the application of biosensors is well established, current instrumentation has limited sampling throughput. Sc...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-11-097
Budget: 09/01/12 - 08/30/13

Project Summary The goal of this Phase II STTR project is to develop a real-time label-free biosensor that can analyze 96 samples at a time, compared to the 6 samples possible with current technologies. This platform will initially be demonstrated with G-protein-coupled receptors (GPCRs) and antibodies. What both applications have in common is t...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-215
Budget: 09/01/12 - 08/31/13

DESCRIPTION (provided by applicant): The goal of this Phase I SBIR project is to develop a device for automated array printing of lipids and membrane proteins onto submerged microtiter plate surfaces in a way that maintains their activity and function. Our proprietary 3D microfluidic printing technology is uniquely capable of sealing and printin...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-11-097
Budget: 09/23/11 - 08/31/12

DESCRIPTION (provided by applicant): The goal of this Phase II STTR project is to develop a real-time label-free biosensor that can analyze 96 samples at a time, compared to the 6 samples possible with current technologies. This platform will initially be demonstrated with G-protein-coupled receptors (GPCRs) and antibodies. What both application...

Load More